Milrinone

CHEMBL189 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
211.2 g/mol
LogP
Phase
4

This medication strengthens heart contractions and relaxes blood vessels, helping the heart pump more effectively in acute heart failure. It is given intravenously in hospital settings and is not intended for long-term outpatient use.

Khối lượng phân tử

211,2200 g/mol

LogP

0,00

TPSA

65,80 Ų

Lipinski RO5

Đạt

Lĩnh vực điều trị

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1

InChI

InChI=1S/C12H9N3O/c1-8-11(9-2-4-14-5-3-9)6-10(7-13)12(16)15-8/h2-6H,1H3,(H,15,16)

Molecular Formula

C12H9N3O

HBD / HBA

1 / 3

Liên kết có thể quay

1

Nguyên tử nặng

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

This medication strengthens heart contractions and relaxes blood vessels, helping the heart pump more effectively in acute heart failure. It is given intravenously in hospital settings and is not intended for long-term outpatient use.

Yes, Milrinone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL189. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4197. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.